Ken Shirabe

29.6k total citations
859 papers, 17.4k citations indexed

About

Ken Shirabe is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Ken Shirabe has authored 859 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 409 papers in Surgery, 351 papers in Hepatology and 267 papers in Oncology. Recurrent topics in Ken Shirabe's work include Hepatocellular Carcinoma Treatment and Prognosis (197 papers), Liver Disease Diagnosis and Treatment (141 papers) and Liver Disease and Transplantation (138 papers). Ken Shirabe is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (197 papers), Liver Disease Diagnosis and Treatment (141 papers) and Liver Disease and Transplantation (138 papers). Ken Shirabe collaborates with scholars based in Japan, United States and United Kingdom. Ken Shirabe's co-authors include Yoshihiko Maehara, Tomoharu Yoshizumi, Mitsuo Shimada, Norifumi Harimoto, Akinobu Taketomi, Toru Ikegami, Yo‐ichi Yamashita, Yuji Soejima, Hideaki Uchiyama and Keizō Sugimachi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Ken Shirabe

796 papers receiving 17.1k citations

Peers

Countries citing papers authored by Ken Shirabe

Since Specialization

Citations

This map shows the geographic impact of Ken Shirabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Shirabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Shirabe more than expected).

Fields of papers citing papers by Ken Shirabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Shirabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Shirabe. The network helps show where Ken Shirabe may publish in the future.

Co-authorship network of co-authors of Ken Shirabe

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Shirabe. A scholar is included among the top collaborators of Ken Shirabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Shirabe. Ken Shirabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oesophagectomy in the East versus the West: comparison of two national audit databases 2025 ·British journal of surgery ·Satoru Matsuda, (unknown), Hiraku Kumamaru, B. Feike Kingma, Hirofumi Kawakubo, Jelle P. Ruurda, Masayuki Watanabe, Hiroaki Miyata, Sjoerd M. Lagarde, (unknown), Richard van Hillegersberg, Ken Shirabe, Bas P. L. Wijnhoven, Yuko Kitagawa	2
2	Risk model for morbidity and mortality following liver surgery based on a national Japanese database 2024 ·Annals of Gastroenterological Surgery ·Tatsuya Orimo, (unknown), Akinobu Taketomi, Hisateru Tachimori, Taro Oshikiri, Hiroaki Miyata, Yoshihiro Kakeji, Ken Shirabe	2
3	RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation 2024 ·Scientific Reports ·Kouki Hoshino, Seshiru Nakazawa, Takehiko Yokobori, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Kenichiro Araki, Norifumi Harimoto, Fuminori Tokunaga, Ken Shirabe	1
4	A case of resected anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor with literature review 2024 ·Surgical Case Reports ·Norio Kubo, Shigemasa Suzuki, (unknown), (unknown), (unknown), (unknown), Ryusuke Aihara, Akira Mogi, Yuka Yoshida, Kenji Kashiwabara, Yasuo Hosouchi, Ken Shirabe	0
5	Usefulness of Hem-o-lok® clips to ligate the gastroduodenal artery in pancreatoduodenectomy 2024 ·HPB ·Norio Kubo, Shigemasa Suzuki, (unknown), (unknown), (unknown), (unknown), (unknown), Ryusuke Aihara, Kenichiro Araki, Yasuo Hosouchi, Ken Shirabe	0
6	Poorly cohesive gastric cancer with increased epithelial‑mesenchymal transition is associated with a poor prognosis 2024 ·Oncology Letters ·Nobuhiro Nakazawa, Makoto Sohda, Munenori Ide, (unknown), Akihiko Sano, Makoto Sakai, Tetsunari Oyama, Ken Shirabe, Hiroshi Saeki	0
7	Potential of Mac‐2‐binding protein glycan isomer as a new therapeutic target in pancreatic cancer 2024 ·Cancer Science ·Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe	7
8	Pulmonary cavernous hemangioma combined with smooth muscle hyperplasia: a case report and review of the literature 2023 ·PubMed ·Takashi Ibe, Takayuki Kosaka, (unknown), Satoru Kakizaki, Ken Shirabe	1
9	The impact of lymphangiograpy on chyle leakage treatment duration after pancreatic surgery 2023 ·Surgery Today ·Norihiro Ishii, Norifumi Harimoto, (unknown), Ryo Muranushi, Kei Hagiwara, Kouki Hoshino, Mariko Tsukagoshi, Akira Watanabe, Takamichi Igarashi, Kei Shibuya, Kenichiro Araki, Ken Shirabe	2
10	Primary duodenal carcinoma suspected to arise from ectopic gastric mucosa: a case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), Norio Kubo, Shigemasa Suzuki, (unknown), (unknown), (unknown), Ryusuke Aihara, Akira Mogi, Yasuo Hosouchi, Ken Shirabe	1
11	A Retrospective Comparison of the Modified Kakita Method and the Modified Cattel-Warren Anastomosis 2021 ·(unknown), Kenichiro Araki, Norio Kubo, Akira Watanabe, Mariko Tsukagoshi, Norihiro Ishii, Ken Shirabe, Hiroyuki Kuwano, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
12	Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein–coupled Receptor 68 2021 ·Molecular Cancer Therapeutics ·Takahiro Yamanaka, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Tadashi Handa, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Kenichiro Araki, Kazuo Umezawa, Ken Shirabe	22
13	Oncological safety of immediate breast reconstruction with skin- or nipple-sparing mastectomy: the value of tumor-to-dermis distance measured by preoperative ultrasonography 2021 ·World Journal of Surgical Oncology ·Takaaki Fujii, Yuko Nakazawa, (unknown), (unknown), Reina Yajima, Chikako Honda, Hidenori Nakamura, Takaya Makiguchi, Ken Shirabe	10
14	Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer 2020 ·In Vivo ·Takaaki Fujii, (unknown), Yuko Nakazawa, Sasagu Kurozumi, (unknown), Reina Yajima, Ken Shirabe	9
15	Validity of Hepatic or Pancreatic Resection for Elderly Patients Aged 85 Years or Older at a Single Community Hospital in Japan. 2016 ·PubMed ·Shinji Itoh, Shunji Kohnoe, Ken Shirabe, Daisuke Yoshida, Hirofumi Kawanaka, Tomoharu Yoshizumi, Toru Ikegami, (unknown), Takeshi Kurihara, Yoshihiko Maehara	5
16	Optimizing Risk Stratification in Portal Vein Thrombosis after Splenectomy and its Primary Prophylaxis with Antithrombin III Concentrates and Danaparoid Sodium in Liver Cirrhosis with Portal Hypertension 2014 ·Journal of the American College of Surgeons ·Hirofumi Kawanaka, Tomohiko Akahoshi, Shinji Itoh, Tomohiro Iguchi, Norifumi Harimoto, Hideaki Uchiyama, Tomoharu Yoshizumi, Ken Shirabe, Kenji Takenaka, Yoshihiko Maehara	40
17	Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection 1998 ·Cancer ·Ken Shirabe, Mitsuo Shimada, Kiyoshi Kajiyama, Tomonobu Gion, Yasuharu Ikeda, Hirofumi Hasegawa, Kenichi Taguchi, Kenji Takenaka, Keizō Sugimachi	36
18	Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection 1998 ·Cancer ·Ken Shirabe, Mitsuo Shimada, Kiyoshi Kajiyama, Tomonobu Gion, Yasuharu Ikeda, Hirofumi Hasegawa, Kenichi Taguchi, Kenji Takenaka, Keizō Sugimachi	4
19	Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma 1996 ·Cancer ·Ken Shirabe, Kenji Takenaka, Akinobu Taketomi, N. Kawahara, Kazuharu Yamamoto, Mitsuo Shimada, Keizō Sugimachi	79
20	Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma 1996 ·Cancer ·Ken Shirabe, Kenji Takenaka, Akinobu Taketomi, N. Kawahara, Kazuharu Yamamoto, Mitsuo Shimada, Keizō Sugimachi	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact